KURE

Fund Description
KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.
Fund Profile
Fund Name KraneShares MSCI All China Health Care Index ETF
Fund Exchange Ticker KURE
Fund Sponsor Krane Shares
Fund ISIN US5007678353
Net Expense Ratio 0.79 %
Fund Inception Date 1 February 2018
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name MSCI China All Shares Health Care 10/40 Index
Index Provider MSCI
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Emerging Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Asia
Key Statistics
Return As of Date 18 January 2019
Asset Under Management 33.57 Million (USD)
1 Month Total Return 3.09 %
Year To Date Return 9.80 %
1 Year Total Return
3 Year Annualized Total Return
NAV 18.65
Share Outstanding 1,800,000
Top 10 Holdings (18 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
JIANGSU HENGRUI MEDICINE C-A 600276 EQUI 0.0848000000
CSPC PHARMACEUTICAL GROUP LT 1093 EQUI 0.0801000000
SINO BIOPHARMACEUTICAL 1177 EQUI 0.0583000000
SINOPHARM GROUP CO-H 1099 EQUI 0.0506000000
WUXI BIOLOGICS CAYMAN INC 2269 EQUI 0.0377000000
YUNNAN BAIYAO GROUP CO LTD-A 000538 EQUI 0.0356000000
ALIBABA HEALTH INFORMATION T 241 EQUI 0.0309000000
CHINA RESOURCES PHARMACEUTIC 3320 EQUI 0.0222000000
ZHANGZHOU PIENTZEHUANG PHA-A 600436 EQUI 0.0210000000
3SBIO INC 1530 EQUI 0.0209000000